Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Cancer Research|September 26, 2014
SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccinesAbhishek K Srivastava, Gunes Dinc, Rajesh K Sharma, et al.
Tissue Engineering. Part A|February 6, 2024
Bending the Rules: Amplifying PD-L1 Immunoregulatory Function Through Flexible Polyethylene Glycol Synthetic LinkersNicole M Racca, Alexander Dontu, Kayle Riley, et al.
Experimental and Molecular Pathology|May 21, 2009
ProtEx technology for the generation of novel therapeutic cancer vaccinesRich-Henry Schabowsky, Rajesh K Sharma, Shravan Madireddi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand proteinEsma S Yolcu, Xiao Gu, Chantale Lacelle, et al.
Plos One|August 8, 2012
SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γShravan Madireddi, Rich-Henry Schabowsky, Abhishek K Srivastava, et al.
Stem Cells (Dayton, Ohio)|March 17, 2007
Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactionsMichal Pearl-Yafe, Esma S Yolcu, Jerry Stein, et al.
Experimental Hematology|September 25, 2007
Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosisMichal Pearl-Yafe, Esma S Yolcu, Jerry Stein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signalingKutlu G Elpek, Esma S Yolcu, Deanna D H Franke, et al.
Pageof 9